ResMed Q4 FY2021 revenue up 14% to $876.1M, dividend increased 8% to $0.42

RESMED INC

2021-FY EPS reported $3.24 revenue$3,196,825,000

Q4 revenue $876.1M (+14% YoY); non-GAAP operating profit up 7%; diluted non-GAAP EPS $1.35.
Full-year FY2021 revenue $3.2B (+8% YoY); non-GAAP operating profit up 12%; non-GAAP EPS $5.33 (+12%).
Quarterly dividend raised 8% to $0.42/share; payable Sep 23, record Aug 19.
Company cites ongoing recovery in sleep apnea patient flow and tailwind from competitor quality issue.
GAAP net income down 24% for FY due to prior-year gain; non-GAAP net income up 13%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.